Cargando…
Targetome analysis of chaperone-mediated autophagy in cancer cells
Chaperone-mediated autophagy (CMA) is a lysosomal degradation pathway of select soluble proteins. Nearly one-third of the soluble proteins are predicted to be recognized by this pathway, yet only a minor fraction of this proteome has been identified as CMA substrates in cancer cells. Here, we undert...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6693453/ https://www.ncbi.nlm.nih.gov/pubmed/30821613 http://dx.doi.org/10.1080/15548627.2019.1586255 |
_version_ | 1783443710035361792 |
---|---|
author | Hao, Yuqing Kacal, Merve Ouchida, Amanda Tomie Zhang, Boxi Norberg, Erik Vakifahmetoglu-Norberg, Helin |
author_facet | Hao, Yuqing Kacal, Merve Ouchida, Amanda Tomie Zhang, Boxi Norberg, Erik Vakifahmetoglu-Norberg, Helin |
author_sort | Hao, Yuqing |
collection | PubMed |
description | Chaperone-mediated autophagy (CMA) is a lysosomal degradation pathway of select soluble proteins. Nearly one-third of the soluble proteins are predicted to be recognized by this pathway, yet only a minor fraction of this proteome has been identified as CMA substrates in cancer cells. Here, we undertook a quantitative multiplex mass spectrometry approach to study the proteome of isolated lysosomes in cancer cells during CMA-activated conditions. By integrating bioinformatics analyses, we identified and categorized proteins of multiple cellular pathways that were specifically targeted by CMA. Beyond verifying metabolic pathways, we show that multiple components involved in select biological processes, including cellular translation, was specifically targeted for degradation by CMA. In particular, several proteins of the translation initiation complex were identified as bona fide CMA substrates in multiple cancer cell lines of distinct origin and we show that CMA suppresses cellular translation. We further show that the identified CMA substrates display high expression in multiple primary cancers compared to their normal counterparts. Combined, these findings uncover cellular processes affected by CMA and reveal a new role for CMA in the control of translation in cancer cells. Abbreviations: 6-AN: 6-aminonicotinamide; ACTB: actin beta; AR7: atypical retinoid 7; CHX: cycloheximide; CMA: chaperone-mediated autophagy; CQ: chloroquine; CTS: cathepsins; DDX3X: DEAD-box helicase 3 X-linked; EEF2: eukaryotic translation elongation factor 2; EIF4A1: eukaryotic translation initiation factor 4A1; EIF4H: eukaryotic translation initiation factor 4H; GEO: Gene Expression Omnibus; GO: Gene Ontology; GSEA: gene set enrichment analysis; HK2: hexokinase 2; HSPA8/HSC70: heat shock protein family A (Hsp70) member 8; LAMP: lysosomal-associated membrane protein; LDHA: lactate dehydrogenase A; NES: normalized enrichment score; NFKBIA: NFKB inhibitor alpha; PCA: principle component analysis; PQ: paraquat; S.D.: standard deviation; SUnSET: surface sensing of translation; TMT: tandem mass tags; TOMM40/TOM40: translocase of outer mitochondrial membrane 40. |
format | Online Article Text |
id | pubmed-6693453 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Taylor & Francis |
record_format | MEDLINE/PubMed |
spelling | pubmed-66934532019-08-26 Targetome analysis of chaperone-mediated autophagy in cancer cells Hao, Yuqing Kacal, Merve Ouchida, Amanda Tomie Zhang, Boxi Norberg, Erik Vakifahmetoglu-Norberg, Helin Autophagy Research Paper Chaperone-mediated autophagy (CMA) is a lysosomal degradation pathway of select soluble proteins. Nearly one-third of the soluble proteins are predicted to be recognized by this pathway, yet only a minor fraction of this proteome has been identified as CMA substrates in cancer cells. Here, we undertook a quantitative multiplex mass spectrometry approach to study the proteome of isolated lysosomes in cancer cells during CMA-activated conditions. By integrating bioinformatics analyses, we identified and categorized proteins of multiple cellular pathways that were specifically targeted by CMA. Beyond verifying metabolic pathways, we show that multiple components involved in select biological processes, including cellular translation, was specifically targeted for degradation by CMA. In particular, several proteins of the translation initiation complex were identified as bona fide CMA substrates in multiple cancer cell lines of distinct origin and we show that CMA suppresses cellular translation. We further show that the identified CMA substrates display high expression in multiple primary cancers compared to their normal counterparts. Combined, these findings uncover cellular processes affected by CMA and reveal a new role for CMA in the control of translation in cancer cells. Abbreviations: 6-AN: 6-aminonicotinamide; ACTB: actin beta; AR7: atypical retinoid 7; CHX: cycloheximide; CMA: chaperone-mediated autophagy; CQ: chloroquine; CTS: cathepsins; DDX3X: DEAD-box helicase 3 X-linked; EEF2: eukaryotic translation elongation factor 2; EIF4A1: eukaryotic translation initiation factor 4A1; EIF4H: eukaryotic translation initiation factor 4H; GEO: Gene Expression Omnibus; GO: Gene Ontology; GSEA: gene set enrichment analysis; HK2: hexokinase 2; HSPA8/HSC70: heat shock protein family A (Hsp70) member 8; LAMP: lysosomal-associated membrane protein; LDHA: lactate dehydrogenase A; NES: normalized enrichment score; NFKBIA: NFKB inhibitor alpha; PCA: principle component analysis; PQ: paraquat; S.D.: standard deviation; SUnSET: surface sensing of translation; TMT: tandem mass tags; TOMM40/TOM40: translocase of outer mitochondrial membrane 40. Taylor & Francis 2019-03-20 /pmc/articles/PMC6693453/ /pubmed/30821613 http://dx.doi.org/10.1080/15548627.2019.1586255 Text en © 2019 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way. |
spellingShingle | Research Paper Hao, Yuqing Kacal, Merve Ouchida, Amanda Tomie Zhang, Boxi Norberg, Erik Vakifahmetoglu-Norberg, Helin Targetome analysis of chaperone-mediated autophagy in cancer cells |
title | Targetome analysis of chaperone-mediated autophagy in cancer cells |
title_full | Targetome analysis of chaperone-mediated autophagy in cancer cells |
title_fullStr | Targetome analysis of chaperone-mediated autophagy in cancer cells |
title_full_unstemmed | Targetome analysis of chaperone-mediated autophagy in cancer cells |
title_short | Targetome analysis of chaperone-mediated autophagy in cancer cells |
title_sort | targetome analysis of chaperone-mediated autophagy in cancer cells |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6693453/ https://www.ncbi.nlm.nih.gov/pubmed/30821613 http://dx.doi.org/10.1080/15548627.2019.1586255 |
work_keys_str_mv | AT haoyuqing targetomeanalysisofchaperonemediatedautophagyincancercells AT kacalmerve targetomeanalysisofchaperonemediatedautophagyincancercells AT ouchidaamandatomie targetomeanalysisofchaperonemediatedautophagyincancercells AT zhangboxi targetomeanalysisofchaperonemediatedautophagyincancercells AT norbergerik targetomeanalysisofchaperonemediatedautophagyincancercells AT vakifahmetoglunorberghelin targetomeanalysisofchaperonemediatedautophagyincancercells |